BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

814 related articles for article (PubMed ID: 19786773)

  • 1. Prebiotics, probiotics and helminths: the 'natural' solution?
    Guarner F
    Dig Dis; 2009; 27(3):412-7. PubMed ID: 19786773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prebiotics in inflammatory bowel diseases.
    Guarner F
    Br J Nutr; 2007 Oct; 98 Suppl 1():S85-9. PubMed ID: 17922967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials.
    Hedin C; Whelan K; Lindsay JO
    Proc Nutr Soc; 2007 Aug; 66(3):307-15. PubMed ID: 17637082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there any place for alimentary probiotics, prebiotics or synbiotics, for patients with inflammatory bowel disease?
    Seksik P; Dray X; Sokol H; Marteau P
    Mol Nutr Food Res; 2008 Aug; 52(8):906-12. PubMed ID: 18384087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probiotics for inflammatory bowel disease: a critical appraisal.
    Sans M
    Dig Dis; 2009; 27 Suppl 1():111-4. PubMed ID: 20203506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microecology as a target for therapeutic intervention in inflammatory bowel disease.
    Guarner F
    IDrugs; 2003 Sep; 6(9):868-73. PubMed ID: 12964066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prebiotics, synbiotics and inflammatory bowel disease.
    Steed H; Macfarlane GT; Macfarlane S
    Mol Nutr Food Res; 2008 Aug; 52(8):898-905. PubMed ID: 18383235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiota and inflammatory bowel disease.
    Hammer HF
    Dig Dis; 2011; 29(6):550-3. PubMed ID: 22179210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacteriotherapy for inflammatory bowel disease: therapeutic tool and/or pharmacological vectors?
    Marteau P; Sokol H; Dray X; Seksik P
    Gastroenterol Clin Biol; 2009 Jun; 33 Suppl 3():S228-34. PubMed ID: 20117346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probiotics in inflammatory bowel disease--therapeutic rationale and role.
    Shanahan F
    Adv Drug Deliv Rev; 2004 Apr; 56(6):809-18. PubMed ID: 15063591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probiotics, prebiotics and symbiotics in inflammatory bowel diseases: state-of-the-art and new insights.
    Sinagra E; Tomasello G; Cappello F; Leone A; Cottone M; Bellavia M; Rossi F; Facella T; Damiani P; Zeenny MN; Damiani F; Abruzzo A; Damiano G; Palumbo VD; Cocchi M; Jurjus A; Spinelli G; Lo Monte AI; Raimondo D
    J Biol Regul Homeost Agents; 2013; 27(4):919-33. PubMed ID: 24382173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probiotics as modulators of the gut flora.
    Fooks LJ; Gibson GR
    Br J Nutr; 2002 Sep; 88 Suppl 1():S39-49. PubMed ID: 12215180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probiotics, prebiotics and antibiotics in inflammatory bowel disease.
    Cummings JH; Kong SC
    Novartis Found Symp; 2004; 263():99-111; discussion 111-4, 211-8. PubMed ID: 15669637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of microecology in chronic inflammatory bowel diseases.
    Guarner F; Casellas F; Borruel N; AntolĂ­n M; Videla S; Vilaseca J; Malagelada JR
    Eur J Clin Nutr; 2002 Dec; 56 Suppl 4():S34-8. PubMed ID: 12556945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microflora: a new target for therapeutic approaches in inflammatory bowel disease.
    Mitsuyama K; Sata M
    Expert Opin Ther Targets; 2008 Mar; 12(3):301-12. PubMed ID: 18269340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of intestinal flora in inflammatory bowel disease and probiotics place in their management].
    Belkahla N; Maamouri N; Ouerghi H; Ben Ammar A
    Tunis Med; 2005 Mar; 83(3):132-6. PubMed ID: 15929439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical usefulness of probiotics in inflammatory bowel diseases.
    Mach T
    J Physiol Pharmacol; 2006 Nov; 57 Suppl 9():23-33. PubMed ID: 17242485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helminths and mucosal immune modulation.
    Weinstock JV
    Ann N Y Acad Sci; 2006 Aug; 1072():356-64. PubMed ID: 17057216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory bowel disease: current insights into pathogenesis and new therapeutic options; probiotics, prebiotics and synbiotics.
    Geier MS; Butler RN; Howarth GS
    Int J Food Microbiol; 2007 Apr; 115(1):1-11. PubMed ID: 17137666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of disease: the hygiene hypothesis revisited.
    Guarner F; Bourdet-Sicard R; Brandtzaeg P; Gill HS; McGuirk P; van Eden W; Versalovic J; Weinstock JV; Rook GA
    Nat Clin Pract Gastroenterol Hepatol; 2006 May; 3(5):275-84. PubMed ID: 16673007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.